John M. Leedom

8.9k citations
75 papers · 6.3k indexed · 2 hit papers · h-index 29
Topics
HIV/AIDS drug development and treatment (15 papers)HIV/AIDS Research and Interventions (13 papers)Pneumocystis jirovecii pneumonia detection and treatment (12 papers)

In The Last Decade

John M. Leedom

74 papers receiving 5.9k citations

Hit Papers

The Efficacy of Azidothymidine (AZT) in the Treatment of ...19872026200020131987198750010001.5k2.0k

Peers

John M. Leedom
Comparison fields: 5 of 143
  • Infectious Diseases 3.9k
  • Epidemiology 3.0k
  • Virology 2.2k
  • Molecular Biology 575
  • Immunology 495
Replace David T. Durack with:
David T. Durack United States
Michael H. Grieco United States
Arthur E. Brown United States
Craig M. Wilson United States
Tomàs Pumarola Spain
Constance A. Benson United States
Clyde S. Crumpacker United States
Michael S. Gottlieb United States
Donna Mildvan United States
P A Pizzo United States
John M. Leedom relative to David T. Durack United States David T. Durack's profile →
Citations per field
00.5×1.5×
David T. Durack · 1×
Citations per year

Countries citing papers authored by John M. Leedom

Since Specialization
Citations

This map shows the geographic impact of John M. Leedom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Leedom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Leedom more than expected).

Fields of papers citing papers by John M. Leedom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Leedom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Leedom. The network helps show where John M. Leedom may publish in the future.

Co-authorship network of co-authors of John M. Leedom

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Leedom. A scholar is included among the top collaborators of John M. Leedom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Leedom. John M. Leedom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 84
3 58
4 7
5 26
6 65
7 14
8 147
9 9
10 10
11 29
12 15
13 161
14 153
15 20
16 15
17 251
18 37
19 16
20
ASEPTIC MENINGITIS ASSOCIATED WITH ECHO VIRUS TYPE 9 INFECTION. WITH SPECIAL REFERENCE TO VARIABILITY BY SEX AND INCIDENCE OF PARALYTIC SEQUELAE.
3

About John M. Leedom

John M. Leedom is a scholar working on Virology, Microbiology and Infectious Diseases, having authored 75 papers that have together received 6.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). The work is most often cited by research in Virology (2.2k citations), Infectious Diseases (3.9k citations) and Epidemiology (3.0k citations). John M. Leedom has collaborated with scholars based in United States, France and New Zealand. Frequent co-authors include Douglas D. Richman, George Gee Jackson, Margaret A. Fischl, Michael H. Grieco, Michael S. Gottlieb, Donna Mildvan, Paul A. Volberding, Oscar L. Laskin, Jerome E. Groopman and David T. Durack. Their work appears in journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026